What BMI Do You Need to Qualify for Semaglutide Weight Loss?
Dr. Shima Hadidchi, MD, provides guidance on qualifying for Semaglutide weight loss, generally recommended for patients with a BMI of 30+ or 27+ with weight-related health conditions. Dr. Hadidchi customizes treatment based on individual health profiles, ensuring safe and effective weight loss solutions. For more information, please contact us today or book an appointment online now! We have convenient locations in Apple Valley, CA and Victorville, CA.
Table of Contents:
What BMI qualifies for semaglutide treatment?
Can individuals with a BMI under 27 use semaglutide for weight loss?
How does semaglutide affect BMI?
Is semaglutide suitable for individuals with a BMI over 40?
At the medical practice of Dr. Shima Hadidchi MD, we understand the complexities of weight management and the significant role it plays in overall health. We offer personalized consultation and treatment options, including the prescription of Semaglutide for eligible patients.
Semaglutide is a medication primarily used for chronic weight management in adults. It’s typically recommended for those with a Body Mass Index (BMI) of 30 kg/m² or higher, which falls within the obesity range. However, at our practice, we also consider patients with a BMI of 27 to 29.9 kg/m² (overweight category), but only if they have at least one serious weight-related health issue.
We want to emphasize that the decision to prescribe semaglutide is not based solely on BMI. Dr. Hadidchi will also thoroughly assess your medical history, current health status, and lifestyle factors to determine the appropriateness of this treatment.
Semaglutide is not intended for use in individuals with a BMI below 27 kg/m², as its safety and effectiveness in this population have not been established. We strongly recommend setting up a consultation with Dr. Hadidchi to discuss your individual weight management goals and circumstances and to assess whether semaglutide treatment is right for you.
Recently, semaglutide has been approved as a medication for weight loss management. While this is the main target population, there are circumstances where people with a BMI under 27 may stand to benefit from semaglutide under stringent medical supervision.
Dr. Hadidchi emphasizes the importance of evaluating each patient’s overall health status, including any underlying medical conditions such as type 2 diabetes or high blood pressure that could benefit from weight loss. However, it’s important to note that using semaglutide for weight loss in individuals with a BMI below 27 is not currently supported by clinical data or FDA approval.
Potential side effects of semaglutide, such as nausea, vomiting, and diarrhea due to appetite suppression and slower gastric emptying, could be more pronounced in individuals with a lower BMI. Hence, the potential benefits and risks must be thoroughly discussed with Dr. Shima Hadidchi or her healthcare team before beginning a treatment regimen with semaglutide.
Semaglutide should not be taken by pregnant women, people with histories of pancreatitis, thyroid cancer, or multiple endocrine neoplasia syndrome type 2.
For individuals with a BMI below 27 seeking to lose weight, it is critical to consult with healthcare professionals like Dr. Shima Hadidchi. She and her team can provide appropriate and effective weight loss strategies that are tailored to your health status and personal goals.
At our medical practice, we focus on a comprehensive approach to health and wellness. Semaglutide, an innovative medication, is part of our treatment arsenal, particularly for patients dealing with type 2 diabetes and weight management.
In our practice, we often recommend semaglutide for patients struggling with weight management. Semaglutide’s multifaceted mechanism of action helps reduce caloric intake by lowering hunger and increasing feelings of fullness. By binding to GLP-1 receptors in the hypothalamus, it influences the release of hormones that contribute to this effect.
Semaglutide also improves insulin sensitivity, reduces inflammation, and encourages increased physical activity—all vital components in managing a healthy weight.
In our clinical experience, we have seen strong results with semaglutide, particularly when it is used in conjunction with a reduced-calorie diet and regular exercise. Patients have typically achieved significant weight loss over time, with some reports of a 15-20% reduction in initial body weight for 60-104 weeks.
Dr. Shima Hadidchi MD and her team are experienced in administering semaglutide and monitoring its effects. We gradually increase the dosage over time to allow the body to adjust and minimize potential gastrointestinal side effects.
However, it’s crucial to remember that semaglutide is not suitable for everyone. Patients with a history of thyroid tumors or certain types of thyroid disease may need to explore alternative treatment options. We recommend you consult with us to assess if you can be a candidate for semaglutide therapy for weight loss.
Recent studies have indicated its potential efficacy in assisting with weight loss in individuals with a BMI over 40.
Semaglutide is now recommended by the FDA for chronic weight management in patients with a BMI greater than 30 kg/m2 or 27 kg/m2 but having at least one obesity-related comorbidity. This makes it a standard management option for the individuals visiting Dr. Shima Hadidchi MD’s practice with obesity, high blood pressure, type 2 diabetes, or high cholesterol.
The long-term efficacy and maintenance of weight loss with semaglutide are still under investigation. Nevertheless, preliminary findings suggest that it can maintain weight loss for up to 5 years, given adherence to dietary and lifestyle changes.
As with any medication, semaglutide may not be suitable for everyone and can cause side effects such as nausea, diarrhea, vomiting, and the like. Hence, it is recommended that all patients at Dr. Shima Hadidchi MD’s practice be closely observed while on this medicine.
However, it should not be taken by patients with a family history of medullary thyroid carcinoma or having multiple endocrine neoplasia type 2.
We evaluate the suitability of semaglutide on a case-by-case basis, considering overall health, medical history, and individual goals. In conclusion, semaglutide may be a viable treatment option for our patients with a BMI over 40 who have struggled with weight loss through traditional methods. However, it’s vital to collaborate closely with Dr. Shima Hadidchi MD, and her team to ensure that semaglutide is the right choice for each unique patient’s needs. Visit us now. For more information, please contact us today or book an appointment online now. We serve patients from Victorville CA, Apple Valley CA, Adelanto CA, Hesperia CA, Crestline CA, Highland CA, Barstow CA, and BEYOND!
Additional Services You May Need
▸ Telemedicine
▸ Family Practice And Primary Care
▸ Walk-Ins
▸ Weight Loss Management
▸ Women’s Health
▸ Vaccinations & Immunizations
▸ Diabetes Management
▸ Geriatrics
▸ Pediatrics
▸ Internal Medicine
▸ Acne Treatment
▸ Cryotherapy Treatment
▸ Skin Lesion Removal
▸ Dementia Treatment
▸ Semaglutide Injections
Additional Services You May Need